Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Teng, Zhaoqian, Chen, Chu
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
https://ncbi.nlm.nih.gov/pubmed/23122958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2012.09.030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados